Ensign Peak Advisors
ELV icon

Ensign Peak Advisors’s Elevance Health ELV Stock Holding History

Ensign Peak Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$62.1M Buy
160,623
+23,072
+17% +$8.56M 0.1% 174
2026
Q1 		$40.3M Sell
137,551
-6,983
-5% -$2.3M 0.08% 208
2025
Q4 		$50.7M Sell
144,534
-5,058
-3% -$1.71M 0.09% 185
2025
Q3 		$48.3M Sell
149,592
-30,791
-17% -$9.58M 0.08% 206
2025
Q2 		$70.2M Sell
180,383
-13,325
-7% -$5.36M 0.12% 158
2025
Q1 		$84.3M Buy
193,708
+62,619
+48% +$25.1M 0.16% 132
2024
Q4 		$48.4M Sell
131,089
-3,671
-3% -$1.54M 0.09% 194
2024
Q3 		$70.1M Buy
134,760
+74,645
+124% +$39.9M 0.12% 144
2024
Q2 		$32.6M Buy
60,115
+2,862
+5% +$1.51M 0.06% 226
2024
Q1 		$29.7M Sell
57,253
-25,434
-31% -$12.6M 0.05% 254
2023
Q4 		$39M Sell
82,687
-78,202
-49% -$36.2M 0.08% 215
2023
Q3 		$70.1M Buy
160,889
+2,799
+2% +$1.27M 0.15% 130
2023
Q2 		$70.2M Sell
158,090
-19,037
-11% -$8.78M 0.14% 132
2023
Q1 		$81.4M Sell
177,127
-77,243
-30% -$36.8M 0.18% 118
2022
Q4 		$130M Sell
254,370
-3,412
-1% -$1.73M 0.29% 86
2022
Q3 		$117M Buy
257,782
+26,720
+12% +$12.8M 0.29% 81
2022
Q2 		$112M Sell
231,062
-26,132
-10% -$12.9M 0.27% 89
2022
Q1 		$126M Buy
257,194
+27,358
+12% +$12.5M 0.26% 92
2021
Q4 		$107M Buy
229,836
+6,160
+3% +$2.59M 0.2% 110
2021
Q3 		$83.4M Buy
223,676
+48,039
+27% +$18.3M 0.17% 126
2021
Q2 		$67.1M Buy
175,637
+5,385
+3% +$2.06M 0.14% 148
2021
Q1 		$61.1M Sell
170,252
-16,671
-9% -$5.36M 0.13% 151
2020
Q4 		$60M Sell
186,923
-40,046
-18% -$12.3M 0.14% 145
2020
Q3 		$61M Sell
226,969
-1,661
-0.7% -$447K 0.15% 120
2020
Q2 		$60.1M Buy
228,630
+100,159
+78% +$26.7M 0.16% 118
2020
Q1 		$29.2M Buy
128,471
+35,721
+39% +$9.73M 0.1% 157
2019
Q4 		$28M Buy
+92,750
New +$25.5M 0.07% 234

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Ensign Peak Advisors's ELV Position: Q2 2026 in Review

Ensign Peak Advisors increased its Elevance Health (ELV) stake by 17% in Q2 2026, buying an estimated $8.56M and bringing the position to 160,623 shares worth $62.1M. The position accounts for 0.1% of the portfolio, ranked #174.

Ensign Peak Advisors first reported a position in ELV in Q4 2019 and has held it in 27 quarters since. The position peaked at $130M in Q4 2022. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Ensign Peak Advisors held 160,623 shares of Elevance Health worth $62.1M as of Q2 2026.
  • Ensign Peak Advisors bought 23,072 Elevance Health shares in Q2 2026, an estimated $8.56M.
  • Elevance Health made up 0.1% of Ensign Peak Advisors's portfolio in Q2 2026, its #174 holding.
  • Ensign Peak Advisors first reported a position in Elevance Health in Q4 2019 and has held it in 27 quarters since.
  • Ensign Peak Advisors's Elevance Health position peaked at $130M in Q4 2022.
  • 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.